BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 29295892)

  • 1. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
    Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
    Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients.
    Bandino A; Geerts D; Koster J; Bachmann AS
    Cell Oncol (Dordr); 2014 Dec; 37(6):387-98. PubMed ID: 25315710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spermidine analogue GC7 (N1-guanyl-1,7-diamineoheptane) induces autophagy through a mechanism not involving the hypusination of eIF5A.
    Oliverio S; Corazzari M; Sestito C; Piredda L; Ippolito G; Piacentini M
    Amino Acids; 2014 Dec; 46(12):2767-76. PubMed ID: 25218134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent roles of eIF5A and polyamines in cell proliferation.
    Nishimura K; Murozumi K; Shirahata A; Park MH; Kashiwagi K; Igarashi K
    Biochem J; 2005 Feb; 385(Pt 3):779-85. PubMed ID: 15377278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomers of 3-methylspermidine selectively modulate deoxyhypusine synthesis and reveal important determinants for spermidine transport.
    Hyvönen MT; Khomutov M; Petit M; Weisell J; Kochetkov SN; Alhonen L; Vepsäläinen J; Khomutov AR; Keinänen TA
    ACS Chem Biol; 2015 Jun; 10(6):1417-24. PubMed ID: 25689365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological targeting of polyamine and hypusine biosynthesis reduces tumour activity of endometrial cancer.
    Kim HI; Schultz CR; Chandramouli GVR; Geerts D; Risinger JI; Bachmann AS
    J Drug Target; 2022 Jul; 30(6):623-633. PubMed ID: 35100927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.
    Nakanishi S; Cleveland JL
    Amino Acids; 2016 Oct; 48(10):2353-62. PubMed ID: 27357307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
    Wolff EC; Kang KR; Kim YS; Park MH
    Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
    Preukschas M; Hagel C; Schulte A; Weber K; Lamszus K; Sievert H; Pällmann N; Bokemeyer C; Hauber J; Braig M; Balabanov S
    PLoS One; 2012; 7(8):e43468. PubMed ID: 22927971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
    Park MH
    J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation.
    Coni S; Serrao SM; Yurtsever ZN; Di Magno L; Bordone R; Bertani C; Licursi V; Ianniello Z; Infante P; Moretti M; Petroni M; Guerrieri F; Fatica A; Macone A; De Smaele E; Di Marcotullio L; Giannini G; Maroder M; Agostinelli E; Canettieri G
    Cell Death Dis; 2020 Dec; 11(12):1045. PubMed ID: 33303756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice.
    Kar RK; Hanner AS; Starost MF; Springer D; Mastracci TL; Mirmira RG; Park MH
    J Biol Chem; 2021 Nov; 297(5):101333. PubMed ID: 34688659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
    Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
    Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy.
    Bourourou M; Gouix E; Melis N; Friard J; Heurteaux C; Tauc M; Blondeau N
    J Cereb Blood Flow Metab; 2021 May; 41(5):1080-1090. PubMed ID: 32615885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.
    Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS
    Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation.
    Liu Y; Xue F; Zhang Y; Lei P; Wang Z; Zhu Z; Sun K
    Anticancer Drugs; 2017 Nov; 28(10):1097-1105. PubMed ID: 28885268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inhibitors of deoxyhypusine synthase on the differentiation of mouse neuroblastoma and erythroleukemia cells.
    Chen ZP; Yan YP; Ding QJ; Knapp S; Potenza JA; Schugar HJ; Chen KY
    Cancer Lett; 1996 Aug; 105(2):233-9. PubMed ID: 8697449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Eukaryotic Translation Initiation Factor 5A (eIF5A) Hypusination Suppress p53 Translation and Alters the Association of eIF5A to the Ribosomes.
    Martella M; Catalanotto C; Talora C; La Teana A; Londei P; Benelli D
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. eIF5A-Independent Role of DHPS in p21
    Becker AE; Wu PK; Park JI
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
    Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
    Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.